G
Grand Pharmaceutical Group Ltd
HKEX:512
Grand Pharmaceutical Group Ltd
HKEX:512
Price:
6.58
HKD
0.46%
Market Cap:
HK$23.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
HK |
|
Z
|
Zinzino AB
STO:ZZ B
|
SE |
|
Valmet Oyj
OTC:VOYJF
|
FI |
|
Amper SA
MAD:AMP
|
ES |
|
Vakrangee Limited
NSE:VAKRANGEE
|
IN |
|
J & J Snack Foods Corp
NASDAQ:JJSF
|
US |
|
N
|
Nusantara Infrastructure Tbk PT
IDX:META
|
ID |
|
Arman Financial Services Ltd
NSE:ARMANFIN
|
IN |
|
Knot Offshore Partners LP
NYSE:KNOP
|
UK |
|
Environmental Waste International Inc
XTSX:EWS
|
CA |
|
D
|
Dongguan Dingtong Precision Metal Co Ltd
SSE:688668
|
CN |
|
A
|
AJ Advance Technology PCL
SET:AJA
|
TH |
|
1
|
1895 Bancorp of Wisconsin Inc
NASDAQ:BCOW
|
US |
|
Belrise Industries Ltd
NSE:BELRISE
|
IN |
|
Kakiyasu Honten Co Ltd
TSE:2294
|
JP |
|
T
|
Tianjin Capital Environmental Protection Group Co Ltd
HKEX:1065
|
CN |
|
clearvise AG
XETRA:ABO
|
DE |
|
N
|
Nakamoto Packs Co Ltd
TSE:7811
|
JP |
|
Twilio Inc
NYSE:TWLO
|
US |
|
Uniphar PLC
LSE:UPR
|
IE |
|
RWE AG
XETRA:RWE
|
DE |
|
J
|
JiShi Media Co Ltd
SSE:601929
|
CN |
|
H
|
Hitevision Co Ltd
SZSE:002955
|
CN |
|
Trutankless Inc
OTC:TKLS
|
US |
Relative Value
The Relative Value of one Grand Pharmaceutical Group Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 6.58 HKD, Grand Pharmaceutical Group Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Grand Pharmaceutical Group Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Grand Pharmaceutical Group Ltd Competitors
Grand Pharmaceutical Group Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| HK |
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
22.9B HKD | 2 | 11.1 | 11.9 | 11.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
860.3B USD | 13.2 | 41.7 | 28.1 | 30 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.9B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 3.9 | 18.6 | 11.1 | 12.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.5B GBP | 4.9 | 28 | 15.6 | 21.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.3B USD | 4.4 | 15.7 | 9.7 | 11.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
221.8B CHF | 5.1 | 20.6 | 12.8 | 16.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD | 2.4 | 19.6 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.7B USD | 2.4 | 16.3 | 6.9 | 8.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
